Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2025-12-25 @ 3:58 PM
Study NCT ID:
NCT04313868
Status:
COMPLETED
Last Update Posted:
2024-11-06
First Post:
2020-01-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
GEN2 Directed Cancer Immunotherapy Trial
Sponsor:
GenVivo, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06-13
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-12
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-15
First Submit QC Date:
None
Study First Post Date:
2020-03-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-05
Last Update Post Date:
2024-11-06
Last Update Post Date Type:
ACTUAL